Bloomberg Law News: Bluebird Is Sued Over Patents Related to Blood-Disease Drug
Bluebird Bio’s LentiGlobin and Zynteglo infringe two patents for recombinant vectors used in the treatment of rare blood disorders, closely held Errant Gene Therapeutics claims in a new lawsuit.
View the rest of the article here
+1 (312) 441-1800
San Rocco Therapeutics
308 E. Emily St.
Tampa, FL 33603